148 related articles for article (PubMed ID: 17083481)
1. Platelet-activating factor and human meningiomas.
Denizot Y; De Armas R; Caire F; Pommepuy I; Truffinet V; Labrousse F
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):674-8. PubMed ID: 17083481
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor and human thyroid cancer.
Denizot Y; Chianéa T; Labrousse F; Truffinet V; Delage M; Mathonnet M
Eur J Endocrinol; 2005 Jul; 153(1):31-40. PubMed ID: 15994743
[TBL] [Abstract][Full Text] [Related]
3. Is there a role of platelet-activating factor in human lung cancer?
Denizot Y; Desplat V; Drouet M; Bertin F; Melloni B
Lung Cancer; 2001; 33(2-3):195-202. PubMed ID: 11551414
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.
Mathonnet M; Descottes B; Valleix D; Truffinet V; Labrousse F; Denizot Y
World J Gastroenterol; 2006 May; 12(17):2773-8. PubMed ID: 16718768
[TBL] [Abstract][Full Text] [Related]
5. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients.
Denizot Y; Gainant A; Guglielmi L; Bouvier S; Cubertafond P; Mathonnet M
Oncogene; 2003 Oct; 22(46):7222-4. PubMed ID: 14562051
[TBL] [Abstract][Full Text] [Related]
6. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor and edema surrounding meningiomas.
Hirashima Y; Hayashi N; Fukuda O; Ito H; Endo S; Takaku A
J Neurosurg; 1998 Feb; 88(2):304-7. PubMed ID: 9452240
[TBL] [Abstract][Full Text] [Related]
8. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
10. Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
Chaithra VH; Jacob SP; Lakshmikanth CL; Sumanth MS; Abhilasha KV; Chen CH; Thyagarajan A; Sahu RP; Travers JB; McIntyre TM; Kemparaju K; Marathe GK
J Lipid Res; 2018 Nov; 59(11):2063-2074. PubMed ID: 30139761
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer.
Denizot Y; Truffinet V; Bouvier S; Gainant A; Cubertafond P; Mathonnet M
Mediators Inflamm; 2004 Feb; 13(1):53-4. PubMed ID: 15203567
[TBL] [Abstract][Full Text] [Related]
12. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
Triggiani M; De Marino V; Sofia M; Faraone S; Ambrosio G; Carratù L; Marone G
Am J Respir Crit Care Med; 1997 Jul; 156(1):94-100. PubMed ID: 9230731
[TBL] [Abstract][Full Text] [Related]
13. Analysis of several PLA2 mRNA in human meningiomas.
Denizot Y; De Armas R; Durand K; Robert S; Moreau JJ; Caire F; Weinbreck N; Labrousse F
Mediators Inflamm; 2009; 2009():689430. PubMed ID: 20339511
[TBL] [Abstract][Full Text] [Related]
14. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection.
Seki M; Kosai K; Hara A; Imamura Y; Nakamura S; Kurihara S; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Mukae H; Tashiro T; Kohno S
Jpn J Infect Dis; 2009 Jan; 62(1):6-10. PubMed ID: 19168951
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.
Tsoukatos DC; Brochériou I; Moussis V; Panopoulou CP; Christofidou ED; Koussissis S; Sismanidis S; Ninio E; Siminelakis S
J Lipid Res; 2008 Oct; 49(10):2240-9. PubMed ID: 18587071
[TBL] [Abstract][Full Text] [Related]
16. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.
Liu J; Chen R; Marathe GK; Febbraio M; Zou W; McIntyre TM
Circ Res; 2011 Feb; 108(4):469-77. PubMed ID: 21183738
[TBL] [Abstract][Full Text] [Related]
17. Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers.
Peplow PV
Prostaglandins Leukot Essent Fatty Acids; 1999 Aug; 61(2):65-82. PubMed ID: 10509861
[TBL] [Abstract][Full Text] [Related]
18. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis.
Perry SW; Hamilton JA; Tjoelker LW; Dbaibo G; Dzenko KA; Epstein LG; Hannun Y; Whittaker JS; Dewhurst S; Gelbard HA
J Biol Chem; 1998 Jul; 273(28):17660-4. PubMed ID: 9651362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
